Drug Profile
PF 6263507
Alternative Names: A1-mafodotin; A1-mcMMAF; Anti-5T4 monoclonal antibody - Pfizer; MMAF ADC - Pfizer; PF-06263507Latest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator Oxford BioMedica
- Developer Pfizer
- Class Antineoplastics; Auristatins; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours